TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TLSA

Tiziana Life Sciences Ltd

Healthcare · Biotechnology

1.00$ -2.9% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Tiziana Life Sciences Ltd (TLSA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 48.6% of the shares are freely tradable; institutional investors hold 3.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 3.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 47.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 48.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.7%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 127Mio.

Largest Shareholders

Institutions

Institutions TLSA
Name Stake (%) Shares Change (%) Date
Dauntless Investment Group, LLC 1.70 2,165,231 +23.0 03/31/2026
Mid-American Wealth Advisory Group, Inc. 0.25 323,240 +0.0 06/30/2026
Marshall Wace Asset Management Ltd 0.12 157,566 -44.1 03/31/2026
Zhang Financial LLC 0.10 125,950 +12.6 06/30/2026
UBS Group AG 0.08 95,700 -9.0 03/31/2026
Citadel Advisors Llc 0.06 80,222 +128.6 06/30/2026
The Colony Group LLC 0.06 79,365 -0.8 03/31/2026
Geode Capital Management, LLC 0.06 78,204 +0.0 03/31/2026

Funds

Funds TLSA
Name Stake (%) Shares Change (%) Date
Goldman Sachs Absolute Ret Trckr Instl 0.07 87,033 +7.8 06/30/2026
Fidelity Nasdaq Composite Index 0.07 86,204 +10.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?